George M. Lasezkay, CEO at Clearside Biomedical, Inc. (CLSD), sold 3,330 shares at $2.07 ($7K) on 2020-12-21, disclosed to the SEC on 2020-12-23.
Scheduled sale ($7k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLSD | SELL | 2022-01-20 | $23K | — | Filing → |
| CLSD | SELL | 2022-01-13 | $13K | — | Filing → |
| CLSD | SELL | 2021-09-23 | $23K | — | Filing → |